1. Home
  2. ULBI vs CING Comparison

ULBI vs CING Comparison

Compare ULBI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$6.50

Market Cap

97.6M

Sector

Miscellaneous

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$6.16

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
CING
Founded
1990
2012
Country
United States
United States
Employees
N/A
13
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.6M
93.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ULBI
CING
Price
$6.50
$6.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$36.00
AVG Volume (30 Days)
65.2K
636.3K
Earning Date
03-10-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$191,159,000.00
N/A
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
$556.59
P/E Ratio
N/A
N/A
Revenue Growth
16.24
N/A
52 Week Low
$4.07
$3.20
52 Week High
$9.51
$11.89

Technical Indicators

Market Signals
Indicator
ULBI
CING
Relative Strength Index (RSI) 54.95 43.18
Support Level $6.35 $3.77
Resistance Level $7.24 $6.41
Average True Range (ATR) 0.43 1.10
MACD 0.05 -0.34
Stochastic Oscillator 67.38 0.88

Price Performance

Historical Comparison
ULBI
CING

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: